Your session is about to expire
← Back to Search
Special Light Treatment for Multiple Myeloma
Study Summary
This trial will test how a special light treatment can help Multiple Myeloma patients with their sleep, inflammation and symptoms. 200 people will receive this light over a 2-month period.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You must be proficient in English, able to communicate effectively.You have a serious mental health condition.I am 21 years old or older.I am scheduled for my first stem cell transplant using my own cells.I do not have an active infection, including COVID-19.I have a severe sleep disorder.I have been diagnosed with another cancer within the last 5 years.I have an eye condition that affects how I see light.I have used light therapy before.I am 21 years old or older.I have been diagnosed with Multiple Myeloma.You have the capacity to consent.I am scheduled for my first stem cell transplant using my own cells.I have a history of bipolar disorder or manic episodes.I have had a stem cell transplant using my own cells.
- Group 1: Circadian Effective Lighting (CEL)
- Group 2: Circadian Ineffective Lighting (CIL)
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are researchers still accepting participants for this experiment?
"Affirmative. According to the information on clinicaltrials.gov, this medical experiment is actively recruiting participants after its initial posting on February 1st 2023 and most recent edit of February 10th 2023. Two hundred patients need to be recruited from two different sites for this trial."
How many individuals are being recruited to partake in this investigation?
"Indeed, the data on clinicaltrials.gov verifies that this trial is actively recruiting participants. This medical investigation was initially presented to the public on February 1st 2023 and has been updated as recently as February 10th 2023. The research team aims to include 200 subjects from 2 different sites in their study."
Who else is applying?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What state do they live in?
Share this study with friends
Copy Link
Messenger